新光药业
(300519)
| 流通市值：16.42亿 | | | 总市值：23.02亿 |
| 流通股本：1.14亿 | | | 总股本：1.60亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 379,066,381.63 | 332,024,461.99 | 421,525,513.68 | 311,836,015.14 |
| 交易性金融资产 | 370,000,000 | 400,000,000 | 350,000,000 | 400,000,000 |
| 应收票据及应收账款 | 16,280,759.21 | 11,143,807.58 | 7,422,763.85 | 10,420,140.26 |
| 应收账款 | 16,280,759.21 | 11,143,807.58 | 7,422,763.85 | 10,420,140.26 |
| 应收款项融资 | 249,158.8 | 363,679.64 | 727,538.32 | 688,648 |
| 预付款项 | 1,751,137.65 | 119,663.4 | 1,759,873.76 | 56,535.78 |
| 其他应收款合计 | 66,663.65 | 100,370.89 | 130,391.39 | 160,411.89 |
| 存货 | 35,212,159.44 | 29,016,375.87 | 26,092,534.47 | 43,268,576.42 |
| 其他流动资产 | 810,580.18 | 818,971.12 | 829,061.41 | 910,027.12 |
| 流动资产合计 | 803,436,840.56 | 773,587,330.49 | 808,487,676.88 | 767,340,354.61 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,730,731.55 | 14,977,399.27 | 15,851,941 | 21,500,353.25 |
| 固定资产 | 83,305,729.59 | 86,242,653.32 | 89,549,333.75 | 92,963,260.42 |
| 在建工程 | - | 122,017.7 | - | - |
| 无形资产 | 7,367,557.11 | 7,440,212.9 | 7,512,868.69 | 7,585,524.48 |
| 递延所得税资产 | - | 76,286.35 | - | 26,626.83 |
| 非流动资产合计 | 106,404,018.25 | 108,858,569.54 | 112,914,143.44 | 122,075,764.98 |
| 资产总计 | 909,840,858.81 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 37,126,334.94 | 37,790,639.11 | 35,304,853.07 | 28,580,457.61 |
| 应付账款 | 37,126,334.94 | 37,790,639.11 | 35,304,853.07 | 28,580,457.61 |
| 预收款项 | 17,554.27 | 35,108.56 | 52,662.85 | 70,217.14 |
| 合同负债 | 433,080.03 | 716,334.16 | 4,137,066.94 | 285,307.81 |
| 应付职工薪酬 | 762,854.88 | 702,574.34 | 601,459.75 | 3,568,509.7 |
| 应交税费 | 9,098,383.55 | 5,659,524.84 | 7,819,338.16 | 7,747,640.22 |
| 其他应付款合计 | 1,335,667.26 | 1,158,545.13 | 912,000 | 4,420,453.41 |
| 其他流动负债 | 56,300.4 | 93,123.44 | 537,818.7 | 37,090.01 |
| 流动负债合计 | 48,830,175.33 | 46,155,849.58 | 49,365,199.47 | 44,709,675.9 |
| 非流动负债: | | | | |
| 长期应付款 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 | 2,362,386.46 |
| 递延收益 | 4,575,283.54 | 4,894,460.95 | 5,213,638.36 | 5,532,815.77 |
| 递延所得税负债 | 11,389.4 | - | 28,129.64 | - |
| 非流动负债合计 | 6,949,059.4 | 7,256,847.41 | 7,604,154.46 | 7,895,202.23 |
| 负债合计 | 55,779,234.73 | 53,412,696.99 | 56,969,353.93 | 52,604,878.13 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 | 161,289,034.52 |
| 其他综合收益 | 3,148,264.88 | 2,507,932.44 | 3,251,292.91 | 3,374,043.32 |
| 盈余公积 | 122,307,827.59 | 122,307,827.59 | 122,307,827.59 | 122,307,827.59 |
| 未分配利润 | 407,316,497.09 | 382,928,408.49 | 417,584,311.37 | 389,840,336.03 |
| 归属于母公司股东权益合计 | 854,061,624.08 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 |
| 股东权益合计 | 854,061,624.08 | 829,033,203.04 | 864,432,466.39 | 836,811,241.46 |
| 负债和股东权益合计 | 909,840,858.81 | 882,445,900.03 | 921,401,820.32 | 889,416,119.59 |
| 公告日期 | 2026-10-23 | 2026-08-25 | 2026-04-21 | 2026-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |